Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

832
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
832
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.9K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.7K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.4K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.4K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.7K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

3.3K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Draft charter for asthma in children and young people, inspired by Martha's rule.

Archives of disease in childhood·2026
Same author

Worsening Asthma Outcomes in Australian Adults: A Comparison of Stratified Sample Surveys in 2012 and 2021.

The Medical journal of Australia·2026
Same author

Allergic rhinitis in the elderly. In collaboration with ARIA guidelines.

The journal of allergy and clinical immunology. In practice·2026
Same author

Remission in Global Airway Diseases: EUFOREA Consensus Paper.

Allergy·2026
Same author

[Documentation of biological treatment in asthma].

Pneumologie (Stuttgart, Germany)·2026
Same author

Is the SUNRISE study a new dawn in steroid stewardship?

The Lancet. Respiratory medicine·2026

Related Experiment Video

Updated: Oct 16, 2025

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.0K

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.

Helen K Reddel1, Leonard B Bacharier2, Eric D Bateman3

  • 1The Woolcock Institute of Medical Research and The University of Sydney, Sydney, Australia.

Respirology (Carlton, Vic.)
|October 20, 2021
PubMed
Summary
This summary is machine-generated.

The Global Initiative for Asthma (GINA) strategy now advises against using short-acting beta2-agonists (SABA) alone for asthma. Preferred treatment involves inhaled corticosteroids (ICS) and formoterol for better asthma control and reduced exacerbations.

Keywords:
asthmaasthma diagnosisasthma managementasthma prevention

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.7K

Related Experiment Videos

Last Updated: Oct 16, 2025

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.0K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

22.7K

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Clinical Guidelines

Background:

  • The Global Initiative for Asthma (GINA) Strategy Report provides annual updates for evidence-based asthma management.
  • Previous guidelines recommended short-acting beta2-agonists (SABA) as a primary reliever medication.
  • Concerns exist regarding the risks of SABA-only treatment and overuse, prompting a review of asthma management strategies.

Purpose of the Study:

  • To summarize key recommendations from the GINA 2021 Strategy Report.
  • To highlight recent changes in asthma management and the evidence supporting them.
  • To emphasize a shift away from SABA-only treatment towards inhaled corticosteroid (ICS)-based strategies.

Main Methods:

  • Review of evidence underpinning recent changes in GINA guidelines.
  • Analysis of large trials comparing ICS-formoterol reliever therapy with SABA alone.
  • Summarization of updated treatment recommendations for different age groups and asthma severities.

Main Results:

  • GINA 2021 recommends against SABA-only treatment for adults and adolescents due to risks and ICS benefits.
  • As-needed ICS-formoterol significantly reduces severe exacerbations in mild asthma compared to SABA alone.
  • New treatment tracks (preferred and alternative) are introduced, with Track 1 favoring ICS-formoterol as the reliever.

Conclusions:

  • Asthma management should prioritize ICS-based reliever strategies over SABA-only approaches.
  • GINA 2021 offers updated, evidence-based recommendations for personalized asthma care across all ages.
  • Regular assessment, risk factor management, and self-management are crucial for optimizing asthma outcomes.